Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1991 Sep;66(3):250–255. doi: 10.1136/hrt.66.3.250

British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction.

R Collins 1, D Julian 1
PMCID: PMC1024656  PMID: 1931356

Abstract

Consultant physicians and cardiologists were surveyed early in 1987 and 1989 to document the management policies for the treatment of acute myocardial infarction in United Kingdom hospitals and to assess the influence of major clinical trials on these policies. The response rate to both these surveys was high (84% (1178 physicians) in 1987 and 76% (982 physicians) in 1989). The percentage of physicians that reported using antiplatelet therapy "routinely" in acute myocardial infarction rose from 9% in 1987 to 84% in 1989 while those who reported using it "rarely or never" fell from 42% to 3%. Similarly, "routine" use of fibrinolytic therapy rose from 2% to 68%, and use "rarely or never" fell from 53% to 3%. This increase in the reported use of fibrinolytic therapy was accompanied by greater certainty about its efficacy and relative safety and by a general widening of the indications for its use. The use of other treatments in acute myocardial infarction (for example, the general use of anticoagulants, beta blockers, nitrates, calcium antagonists, or prophylactic antiarrhythmic agents) seemed to change little during this period, although the routine use of coronary angiography and oral anticoagulants after fibrinolytic therapy fell substantially between 1987 and 1989 (from 23% to 4%, and from 24% to 7% respectively). Fibrinolytic and antiplatelet therapy were accepted into the routine management of myocardial infarction during a relatively short period that coincided with the reporting of several positive controlled trial results. Clinical trials have rarely been seen to have had such a great impact on practice. In this case the rapid acceptance of the trial results may have been due to the consistency and reliability of the estimates of the size of the benefits (and risks) of therapy seen in these unusually large studies.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baber N. S., Julian D. G., Lewis J. A., Rose G. Beta blockers after myocardial infarction: have trials changed practice? Br Med J (Clin Res Ed) 1984 Nov 24;289(6456):1431–1432. doi: 10.1136/bmj.289.6456.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burrell C. J., Skehan J. D., Cowley M. L., Barrett C. W., Mills P. G. Districts' use of thrombolytic agents. BMJ. 1990 Jan 27;300(6719):237–238. doi: 10.1136/bmj.300.6719.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins R., Gray R., Godwin J., Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med. 1987 Apr-May;6(3):245–254. doi: 10.1002/sim.4780060308. [DOI] [PubMed] [Google Scholar]
  4. Held P. H., Yusuf S., Furberg C. D. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989 Nov 11;299(6709):1187–1192. doi: 10.1136/bmj.299.6709.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hlatky M. A., Cotugno H. E., Mark D. B., O'Connor C., Califf R. M., Pryor D. B. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol. 1988 Mar 1;61(8):515–518. doi: 10.1016/0002-9149(88)90756-4. [DOI] [PubMed] [Google Scholar]
  6. Hlatky M. A., Cotugno H., O'Connor C., Mark D. B., Pryor D. B., Califf R. M. Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol. 1988 Mar 1;61(8):510–514. doi: 10.1016/0002-9149(88)90755-2. [DOI] [PubMed] [Google Scholar]
  7. Hutchison S. J., Cobbe S. M. Management of myocardial infarction in Scotland: have clinical trials changed practice? Br Med J (Clin Res Ed) 1987 May 16;294(6582):1261–1261. doi: 10.1136/bmj.294.6582.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MacMahon S., Collins R., Peto R., Koster R. W., Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA. 1988 Oct 7;260(13):1910–1916. [PubMed] [Google Scholar]
  9. Simoons M. L., Arnold A. E., Betriu A., de Bono D. P., Col J., Dougherty F. C., von Essen R., Lambertz H., Lubsen J., Meier B. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988 Jan 30;1(8579):197–203. doi: 10.1016/s0140-6736(88)91062-8. [DOI] [PubMed] [Google Scholar]
  10. Topol E. J., Califf R. M., George B. S., Kereiakes D. J., Abbottsmith C. W., Candela R. J., Lee K. L., Pitt B., Stack R. S., O'Neill W. W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987 Sep 3;317(10):581–588. doi: 10.1056/NEJM198709033171001. [DOI] [PubMed] [Google Scholar]
  11. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]
  12. Yusuf S., Collins R., Peto R., Furberg C., Stampfer M. J., Goldhaber S. Z., Hennekens C. H. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul;6(7):556–585. doi: 10.1093/oxfordjournals.eurheartj.a061905. [DOI] [PubMed] [Google Scholar]
  13. Yusuf S., Collins R., Peto R. Why do we need some large, simple randomized trials? Stat Med. 1984 Oct-Dec;3(4):409–422. doi: 10.1002/sim.4780030421. [DOI] [PubMed] [Google Scholar]
  14. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES